W.J. Fokkens

Revision surgery, biologics, or both?

Rhinology 62-4: 385-385, 2024

E.J.A. Schepens - C.J.M. de Haas - E.M. Postma - B. van Dijk - S. Boesveldt - I. Stegeman - D.M.A. Kamalski

The effect of smell training on COVID-19 induced smell loss

Rhinology 62-4: 386-393, 2024

A.K. Hernandez - C. Uhl - A. Haehner - M. Cuevas - T. Hummel

Objective nasal airflow measures in relation to subjective nasal obstruction, trigeminal function, and olfaction in patients with chronic rhinosinusitis

Rhinology 62-4: 394-402, 2024

J.J. Otten - R.J.L. van der Lans - L.B. Benoist - G.F.J.P.M. Adriaensen - R.D. Hoven - V. Verkest - W.J. Fokkens - S. Reitsma

Steroid responsiveness predicts olfactory function recovery in dupilumab treated CRSwNP

Rhinology 62-4: 403-409, 2024

A. Kiricsi - Z. Bella - H. Kraxner - T. Szaloki - Z. Fent - B. Liktor - J. Huszka - P. Laszlo - D. Gobol - F. Helfferich - Z. Vaska - Z. Piski - L. Juhasz-Loisch - B. Horvath - G. Galantai - N. Krisztin - L. Toth - A. Bodi - M. Matuz - L. Lujber - A. Hirschberg

Real-life effectiveness of dupilumab in chronic rhinosinusitis with nasal polyps. Results from eight Hungarian centres with 12-month follow-up

Rhinology 62-4: 410-420, 2024

J. Mullol - J. Sastre - J. Domínguez-Ortega - M. Blanco- Aparicio - J.A. Castillo Vizuete - I. Alobid - M. García-Vitoria - P.I. Palomo-Jiménez

Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain

Rhinology 62-4: 421-431, 2024

S. Xie - Z. Tong - J. Zhang - C. Yang - W. Jiang - H. Zhang

Elevated MIF identified by multiple cytokine analyses facilitates macrophage M2 polarization contributing to postoperative recurrence in chronic rhinosinusitis with nasal polyps

Rhinology 62-4: 432-445, 2024

A. Sánchez-Montalvo - M. Lecocq - E. Bouillet - B. Steelant - S. Gohy - A. Froidure - D. Bullens - C. Pilette - V. Hox

Validation and shortcomings of the most common mouse model of chronic rhinosinusitis with nasal polyps

Rhinology 62-4: 446-456, 2024

S. Uyttebroek - C. Claeyssens - M. Jorissen - L. Dupont - L. Van Gerven

Dual and triple modulator therapy for chronic rhinosinusitis in cystic fibrosis patients

Rhinology 62-4: 457-465, 2024

X. Wang - R. Zheng - W. Liang - H. Qiu - T. Yuan - W. Wang - H. Deng - W. Kong - J. Chen - Y. Bai - Y. Li - Y. Chen - Q. Wu - S. Wu - X. Huang - Z. Shi - Q. Fu - Y. Zhang - Q. Yang

Small extracellular vesicles facilitate epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps via the miR-375-3p/QKI axis

Rhinology 62-4: 466-479, 2024

J.C. Hernaiz-Leonardo - B.M. Alim - A. Pascual - K. Aldossari - J. Fan - S. Alsaleh - A.R. Javer

Development and validation of the Sinonasal Endoscopic Score (SiNES) for chronic rhinosinusitis

Rhinology 62-4: 480-487, 2024

X. Du - M. Zhang - S. Zhang - X. Yan - L. Wang - Z. Zhang - N. Li - L. Yu - Y. Jiang

The differences between sinonasal respiratory epithelial adenomatoid hamartoma and nasal polyps: insights into immunopathology

Rhinology 62-4: 488-495, 2024

T. Mauthe - C.M. Meerwein - F.S. Ryser - C. Brühlmann - A. Yalamanoglu - U.C. Steiner - M.B. Soyka

Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps

Rhinology 62-4: 496-505, 2024

V. Tubita - M. Fuentes - B. Callejas - M. Bantulà - C. Marin - I. Alobid - J. Bartra - A. Valero - J. Roca-Ferrer - J. Mullol

Low levels of miR-143-3p are associated with severe chronic rhinosinusitis with nasal polyps

Rhinology 62-4: 506-508, 2024

O. Sunnergren - C. Alexandersson - F. Eliasson - M. Jangard - Y. Lilja - K. Sandelin - C. Ahlström Emanuelsson

On the outcome of septoplasty

Rhinology 62-4: 509-510, 2024

C.A. Hintschich - S. Le Bon - E. Trecca - S. Saussez - T. Hummel

Taste loss in COVID-19 – psychophysical evidence supporting a low prevalence

Rhinology 62-4: 511-512, 2024